Simply Connect, the digital social prescribing platform and its partner Content Guru, leader in cloud communications solutions, have together been awarded a place on the 2021 NHS England Health Systems Support Framework (HSSF) for social prescribing(1).

Social prescribing is when health professionals refer patients to support in the community, in order to improve health and wellbeing.

Roche (SIX: RO, ROG; OTCQX: RHHBY) has entered an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the development and distribution agreement, the companies will jointly develop an embedded image analysis workflow for pathologists.

CliniSys has won a major contract to deploy a single laboratory information system across Northern Ireland as part of a modernisation programme to create a world-class pathology service for the country.

CliniSys will replace the seven IT systems used by Northern Ireland’s hospital trusts' pathology disciplines and the Northern Ireland Blood Transfusion service with the latest version of WinPath Enterprise.

Healthcare professionals at Queen's Hospital Burton will be better placed to get patients home safely and as early as possible, whilst freeing up urgently needed capacity, with the help of a technology soon to be deployed.

Following the success of the ExtraMed Patient Flow solution at Royal Derby Hospital, where staff have reduced lengths of stay and enhanced care for patients,

From theoretical physics to entrepreneurship propelled by a deadly new virus: DESY physicist Ayan Paul is launching a new app against Corona with his spin-off company. It combines public data with personal information and location, providing users with a highly individualized assessment of their current risk to contract SARS-CoV-2 with recommendations for action.

Today, the U.S. Food and Drug Administration cleared the first new major technological improvement for Computed Tomography (CT) imaging in nearly a decade.

"Computed tomography is an important medical imaging tool that can aid in diagnosing disease, trauma or abnormality; planning and guiding interventional or therapeutic procedures; and monitoring the effectiveness of certain therapies," said Laurel Burk, Ph.D., assistant director of the Diagnostic X-ray Systems Team in the FDA's Center for Devices and Radiological Health.

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals who examine body tissues (pathologists) in the detection of areas that are suspicious for cancer as an adjunct (supplement) to the review of digitally-scanned slide images from prostate biopsies (tissue removed from the body).